Home › Funds › Point72 Asset Management › MXCT
Point72 Asset Management position in MXCT
MAXCYTE INC · Health Care
Latest position (Q2 2026)299.85K sh
Reported value held$368.82K
Portfolio Weight0.00%
First reportedQ3 2022
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2022 | 34.90K | $227.00K | New |
| Q4 2022 | 421.06K | $2.30M | Add |
| Q1 2023 | 34.20K | $169.29K | Reduce |
| Q2 2023 | 101.00K | $463.59K | Add |
| Q3 2023 | 33.20K | $103.58K | Reduce |
| Q3 2025 | 378.04K | $597.30K | New |
| Q4 2025 | 106.15K | $164.53K | Reduce |
| Q2 2026 | 299.85K | $368.82K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding MXCT
- Vanguard Group 5.54M sh · $8.59M · Q4 2025
- Morgan Stanley 3.69M sh · $4.54M · Q2 2026
- BlackRock Inc 3.06M sh · $3.76M · Q2 2026
- Renaissance Technologies 1.91M sh · $2.35M · Q2 2026
- AQR Capital Management 1.88M sh · $2.32M · Q2 2026
- Two Sigma Investments 1.46M sh · $1.80M · Q2 2026
- Geode Capital Management 1.33M sh · $1.63M · Q2 2026
- Goldman Sachs Group 1.24M sh · $1.53M · Q2 2026
- Millennium Management 1.20M sh · $1.48M · Q2 2026
- Marshall Wace 1.01M sh · $1.25M · Q2 2026
- Citadel Advisors 955.72K sh · $1.18M · Q2 2026